Pneumococcal Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
Active, not recruiting
  • Healthy Volunteers
  • Pneumococcal Disease
  • ASP3772
  • PCV13
  • Bryant, Arkansas
  • +16 more
2022-04-06
Apr 6, 2022
P
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 - 2021
Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
2022-03-23
Mar 23, 2022
P
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants
Active, not recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Nedlands, Western Australia, Australia
  • +65 more
2022-03-22
Mar 22, 2022
P
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan
Active, not recruiting
  • Pneumococcal Disease
  • 20vPnC
  • +3 more
  • Itoshima, Fukuoka, Japan
  • +27 more
2022-03-16
Mar 16, 2022
P
Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age - 2021
Completed
  • Pneumococcal Disease
  • Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Mobile, Alabama
  • +62 more
2022-02-25
Feb 25, 2022
P
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age
Active, not recruiting
  • Pneumococcal Disease
  • 20vPnC
  • Fayetteville, Arkansas
  • +41 more
2022-02-25
Feb 25, 2022
P
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants
Active, not recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Birmingham, Alabama
  • +108 more
2022-02-07
Feb 7, 2022
P
Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults - 2019
Completed
Has Results
  • Pneumococcal Disease
  • 20vPnC
  • +3 more
  • Birmingham, Alabama
  • +67 more
2021-11-29
Nov 29, 2021
M
Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)
Active, not recruiting
  • Pneumococcal Disease
  • V114
  • Jeonju-si, Jeonrabugdo, Korea, Republic of
  • +18 more
2021-11-17
Nov 17, 2021
P
20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants
Active, not recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Tucson, Arizona
  • +97 more
2021-11-10
Nov 10, 2021
P
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants
Active, not recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Nagoya-shi, Aichi, Japan
  • +38 more
2021-11-10
Nov 10, 2021
E
Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults - 2021
Completed
  • Pneumococcal Disease
  • EuPCV15
  • Prevenar13
  • Seoul, Korea, Republic of
    The Catholic University of Seoul St.Mary's Hospital
2021-10-06
Oct 6, 2021
A
A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine - 2020
Completed
  • Healthy Volunteers
  • Pneumococcal Disease
  • ASP3772
  • +2 more
  • Banning, California
  • +25 more
2021-09-27
Sep 27, 2021
P
Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination - 2020
Completed
Has Results
  • Pneumococcal Disease
  • 13vPnC
  • +2 more
  • Mobile, Alabama
  • +41 more
2021-02-02
Feb 2, 2021
P
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults - 2019
Completed
Has Results
  • Pneumococcal Disease
  • 20vPnC
  • 13vPnC
  • Anaheim, California
  • +20 more
2020-11-03
Nov 3, 2020
P
Hepatitis B Vaccination in Infants - 2017
Completed
  • Meningococcal Disease
  • +4 more
  • Menjugate
  • +2 more
  • London, United Kingdom
    St George's Vaccien Institute
2020-09-29
Sep 29, 2020
P
Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers - 2016
Completed
Has Results
  • Pneumococcal Disease
    • Kisumu, Kenya
      Kenya Medical Research Institute/Walter Reed Project
    2020-02-03
    Feb 3, 2020
    P
    Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants - 2016
    Completed
    Has Results
    • Pneumococcal Disease
    • SIILPCV10
    • +2 more
    • Fajara, Gambia
      Medical Research Council (MRC) Unit, The Gambia
    2019-06-11
    Jun 11, 2019
    P
    A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci - 2010
    Completed
    • Pneumococcal Disease
      • Stevenage, Hertfordshire, United Kingdom
      • +2 more
      2019-03-20
      Mar 20, 2019
      P
      A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers - 2011
      Completed
      Has Results
      • Pneumococcal Disease
      • Blood draw
      • Longan County, Guangxi, China
      • +9 more
      2018-11-30
      Nov 30, 2018
      P
      Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. - 2013
      Completed
      • Pneumococcal Disease
      • Non Intervention
      • Athens, Attiki, Greece
      • +20 more
      2018-11-30
      Nov 30, 2018
      M
      A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018) - 2013
      Completed
      Has Results
      • Pneumococcal Disease
      • Pneumovax™ 23
      • (no location specified)
      2018-10-01
      Oct 1, 2018
      P
      Post Market Surveillance to Observe Safety of Prevenar13™ in Adults - 2016
      Completed
      Has Results
      • Pneumococcal Disease
      • Non-intervention
      • Jung-gu, Daejeon, Korea, Republic of
      • +26 more
      2017-03-06
      Mar 6, 2017
      P
      Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos - 2014
      Completed
      Has Results
      • Pneumococcal Disease
      • Prevenar 13
      • Lipa City, Batangas, Philippines
      • +120 more
      2016-12-05
      Dec 5, 2016
      U
      Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines
      Completed
      • Pneumococcal Disease
      • Prevenar 13
      • Pneumovax II
      • Oxford, United Kingdom
        Oxford Vaccine Group
      2015-11-06
      Nov 6, 2015